A Phase I, Randomized, Open-Label, Single-Dose, 2-Part, 4-Treatment, 4-Way Crossover Study in Healthy Adult Subjects to Evaluate the Pharmacokinetics of Various AMG 853 Formulations When Administered Under Fasted and Fed Conditions.
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2011
At a glance
- Drugs AMG-853 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 06 Jan 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.